OR WAIT null SECS
Newswise - The effect of ultraviolet germicidal lights installed in office ventilation systems on workers' health and wellbeing was examined in a double-blind multiple crossover trial conducted by investigators Dick Menzies, Julia Popa, James A Hanley, Thomas Rand, Donald K Milton.
The researchers acknowledged that workers in modern office buildings frequently have unexplained work-related symptoms or combinations of symptoms. They assessed whether ultraviolet germicidal irradiation (UVGI) of drip pans and cooling coils within ventilation systems of office buildings would reduce microbial contamination, and thus occupants' work-related symptoms.
The researchers undertook a double blind, multiple crossover trial of 771 participants. In office buildings in Montreal, Canada, UVGI was alternately off for 12 weeks, then turned on for four weeks. The investigators did this three times with UVGI on and three times with it off, for 48 consecutive weeks. Primary outcomes of self-reported work-related symptoms, and secondary outcomes of endotoxin and viable microbial concentrations in air and on surfaces, and other environmental covariates were measured six times.
They discovered that operation of UVGI resulted in 99 percent (95 percent CI 67-100) reduction of microbial and endotoxin concentrations on irradiated surfaces within the ventilation systems. 771 participants appeared to remain masked, and reported no adverse effects. On the basis of within-person estimates, use of UVGI was associated with significantly fewer work-related symptoms overall (adjusted odds ratio 0Â·8 [95 percent CI 0Â·7-0Â·99]), as well as respiratory (0Â·6 [0Â·4-0Â·9]) and mucosal (0Â·7 [0Â·6-0Â·9]) symptoms than was non-use.
Reduction of work-related mucosal symptoms was greatest among atopic workers (0Â·6 [0Â·5-0Â·8]), and never-smokers (0Â·7 [0Â·5-0Â·9]). With UVGI on, never-smokers also had large reduction of work-related respiratory (0Â·4 [0Â·2-0Â·9]), and musculoskeletal symptoms (0Â·5 [0Â·3-0Â·9]).
The investigators summarize that installation of UGVI in most North American offices could resolve work-related symptoms in about 4 million employees, caused by microbial contamination of heating, ventilation, and air-conditioning systems. The cost of UVGI installation could in the long run prove cost-effective compared with the yearly losses from absence because of building-related illness.
Source: The Lancet 2003;362:1785-91